Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1633
This examiner grants 75% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18285000 | MODIFIED VIRUSES AND VIRAL PARTICLES, METHODS OF MAKING, AND USES THEREOF | Non-Final OA | The Regents of the University of California |
| 17784467 | OBSESSIVE-COMPULSIVE DISORDER ANIMAL MODEL AND PRODUCTION METHOD THEREOF | Non-Final OA | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 17778463 | VACCINIA VIRUSES AND METHODS FOR USING VACCINIA VIRUSES | Final Rejection | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 17685457 | ADENO-ASSOCIATED VIRUS FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF | Final Rejection | University of Massachusetts |
| 18289875 | GENE THERAPY FOR DENT DISEASE | Non-Final OA | Wake Forest University Health Sciences |
| 18276886 | NUTRIENT MEDIA FOR CELL CULTURE CONTAINING PLANT PROTEIN HYDROLYSATES | Non-Final OA | Bühler AG |
| 18010964 | GENETICALLY MODIFIED NON-HUMAN ANIMAL EXPRESSING A B2M/FCRN FUSION PROTEIN | Non-Final OA | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. |
| 18273441 | MATURATION AGENT | Non-Final OA | Orizuru Therapeutics, Inc. |
| 17670789 | Novel oncolytic parvoviruses with enhanced cargo capacity, stable shRNA expression cassette and novel immunogenic properties | Final Rejection | Alliance of Cardiovascular Researchers |
| 17605876 | NOCICEPTOR DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS | Non-Final OA | The United States of America as represented by the Secretary of the Department of Health and Human S |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy